MEDIUM · 5.0

CVE-2023-31167

Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') vulnerability in Schweitzer Engineering Laboratories SEL-5036 acSELerator Bay Screen Builder Software on Windows allows R...

Vulnerability Description

Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') vulnerability in Schweitzer Engineering Laboratories SEL-5036 acSELerator Bay Screen Builder Software on Windows allows Relative Path Traversal. SEL acSELerator Bay Screen Builder software is distributed by SEL-5033 SEL acSELerator RTAC, SEL-5030 Quickset, and SEL Compass. CVE-2023-31167 and was patched in the acSELerator Bay Screen Builder release available on 20230602. Please contact SEL for additional details. This issue affects SEL-5036 acSELerator Bay Screen Builder Software: before 1.0.49152.778.

CVSS Score

5.0

MEDIUM

CVSS:3.1/AV:L/AC:L/PR:L/UI:R/S:U/C:N/I:H/A:N
Attack Vector
LOCAL
Attack Complexity
LOW
Privileges Required
LOW
User Interaction
REQUIRED
Scope
UNCHANGED
Confidentiality
NONE
Integrity
HIGH
Availability
NONE

Affected Products

VendorProductVersions
SelincSel-5036 Acselerator Bay Screen Builder< 1.0.49152.778
MicrosoftWindows-

Related Weaknesses (CWE)

References

FAQ

What is CVE-2023-31167?

CVE-2023-31167 is a vulnerability with a CVSS score of 5.0 (MEDIUM). Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') vulnerability in Schweitzer Engineering Laboratories SEL-5036 acSELerator Bay Screen Builder Software on Windows allows R...

How severe is CVE-2023-31167?

CVE-2023-31167 has been rated MEDIUM with a CVSS base score of 5.0/10. Review the CVSS metrics above for detailed severity breakdown.

Is there a patch for CVE-2023-31167?

Check the references section above for vendor advisories and patch information. Affected products include: Selinc Sel-5036 Acselerator Bay Screen Builder, Microsoft Windows.